MediciNova (MNOV) Proxy filing summary

Executive summary

• The annual meeting is scheduled for June 17, 2025, with proxy materials primarily distributed online and voting available via internet, phone, or mail.

• Stockholders will vote on director election, auditor ratification, executive compensation, and the frequency of say-on-pay votes.

• The board recommends voting for all proposals and a three-year frequency for say-on-pay votes.

Voting matters and shareholder proposals

• Proposals include electing Carolyn Beaver as Class III director, ratifying BDO USA, P.C. as auditor, approving executive compensation, and setting the frequency of say-on-pay votes.

• Stockholders of record as of April 21, 2025, are eligible to vote.

• Shareholder proposals for the 2026 meeting must be submitted by December 29, 2025, for inclusion in proxy materials.

Board of directors and corporate governance

• The board consists of five members in staggered three-year terms; three are independent under NASDAQ rules.

• Committees include Audit, Compensation, and Nominating and Corporate Governance, each chaired by an independent director.

• The board values diversity in experience, skills, and backgrounds and encourages stockholder nominations.